コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 trophic, cyanobacterial cells is a desirable venture.
2 stitutes of Health and Medicines for Malaria Venture.
3 both a time-consuming and financially-taxing venture.
4 GlaxoSmithKline, Medicines for Malaria Venture.
5 rimates has been particularly useful in this venture.
6 enesis is the ultimate multidisciplinary (ad)venture.
7 riologist to grasp the scale and pace of the venture.
8 nzyme functions to treat disease is a costly venture.
9 molecule capture is a novel and challenging venture.
10 trophic, cyanobacterial cells is a desirable venture.
11 on UL138-targeted chemotherapy are important ventures.
12 Peterson Center on Healthcare and Gates Ventures.
13 wiss National Science Foundation, and Arnold Ventures.
14 n and family involvement in supporting green ventures.
15 ccessful implementation in synthetic biology ventures.
16 important to help 'climate proof' shellfish ventures.
17 this 'short-changing' will erode cooperative ventures.
18 the availability of physicians for outreach ventures.
19 ldren's Investment Fund Foundation and Gates Ventures.
21 ited evidence, well over 150 physicians have ventured a perplexing variety of diagnoses of his illnes
22 s and referring to recent mouse studies, and ventures a few extrapolations into the future of this en
24 n partnership with the Medicines for Malaria Venture, an organization dedicated to identifying, devel
25 technology) of the physician entrepreneur's venture and the role that the physician entrepreneur des
26 reates opportunities for firms to form joint ventures and slide down their learning curves more effic
27 nnovators to successfully exit their startup ventures, and terrorist organizations to claim casualtie
28 developing economies through growth in space ventures; and deepening our understanding of the cosmos
31 emains a challenging yet appealing synthetic venture because it circumvents the need to prefunctional
32 it data were obtained from Verispan, a joint venture between Quintiles Transnational and McKesson.
34 aim of improving detection performances, we venture beyond hotspot engineering in this tutorial revi
35 y we are at the brink of yet another step to venture beyond nature's border with the use of unnatural
36 eers, chemists and materials scientists have ventured beyond experiments that merely mimic what happe
39 Secretariats; Fiocruz; Medicines for Malaria Venture; Bill & Melinda Gates Foundation; Newcrest Minin
40 In this issue, Yu et al (2019) tackle this venture by taking advantage of single-cell transcriptomi
43 s the benefits and drawbacks of funding from venture capital firms, grants, friends and family, angel
47 gher income, higher trust, lower taxes, more venture capital investment, and lower regulatory burdens
48 largest companies rooted in technology, and venture capital investments totaling approximately $300B
49 tup outcomes (e.g., whether a startup raises venture capital or gets acquired) remain difficult to fo
50 ncluding its biotech ecosystem and access to venture capital, numerous challenges hinder its full pot
51 ation' holders, which are lower than typical venture-capital hurdle rates but attractive to pension f
54 ities, start-up firms, corporate giants, and venture capitalists play a major role in facilitating th
55 6, he was named to the Midas List of leading venture capitalists, and, in 2013, he was recognized by
56 Finally, in a randomized experiment with 51 venture capitalists, founders were assessed as having a
57 notypic screening of a Medicines for Malaria Venture compound library against Mycobacterium tuberculo
58 fit from education and skills development in venture creation and commercialization of discoveries.
59 ly stage scientists have little knowledge of venture creation and the steps required to develop a dev
60 more sophisticated convolutional models can venture deep into sequence space to design proteins that
62 vestors to consider early-stage life science ventures, especially in the context of a maturing biotec
63 an statisticians as a fruitful and rewarding venture for advancing applied research in parasite epide
66 inberg Neuwirth Fund and Fast Grant Emergent Ventures funding from the Mercatus Center at George Maso
68 hope that they will like what they see, and venture further into the many resources available to go
69 cal Trial Partnership, Medicines for Malaria Venture (Geneva, Switzerland), UK Medical Research Counc
74 tions across time and space: an organism may venture into human-modified areas in benign regions but
78 ophytes and seasoned investigators alike can venture into the emerging realm of cellular metabolism a
81 o-Amazonian layers attests that platanistids ventured into freshwater ecosystems not only in South As
82 t for PROTAC researchers during their future ventures into the complex field of targeted protein degr
83 in a more sustainable direction, seeking new ventures into the space of organic electrosynthesis and
84 vides a roadmap of what could be done before venturing into complex and time-demanding total synthesi
89 An increasingly important feature of this venture is to use experimental data in the design of met
90 V688845, Pathogen Box; Medicines for Malaria Venture; IUPAC: (2R)-N-(1-((2-morpholinophenyl)amino)-1-
92 tion of inhibitors from the Malaria Medicine Venture Malaria Box against the interaction of PfAtg8 wi
93 which according to the Medicines for Malaria Venture (MMV) met the efficacy and drug metabolism and p
94 our collaboration with Medicines for Malaria Venture (MMV) on the IUPHAR/MMV Guide to MALARIA PHARMAC
95 novo screening of the Medicines for Malaria Venture (MMV) Pandemic Response Box against Plasmodium a
96 roach, we screened the Medicines for Malaria Venture (MMV) Pathogen Box to assess the in-vitro antimi
97 initiatives such as the Medicine for Malaria Ventures (MMV), a repository of compounds showing promis
100 rize the current challenges in the field and venture on the steps required to explore novel systems a
101 ing on these findings, an analysis of 20,316 ventures on Crunchbase demonstrates that smiling in prof
103 result, when scientists and engineers first venture out of the laboratory or library with the goal o
105 oved compounds and the Medicines for Malaria Venture Pathogen Box and validated 14 hits (defined as a
108 ociated with outcomes across all phases of a venture's life (i.e., from raising the earliest funding
109 asingly impact the deep sea and, with future ventures such as deep-sea mining on the horizon, describ
110 e collaborators information on when to abort ventures that are not in their interest and opt for ones
115 eveloping global partners and private-public ventures to meet infrastructure and funding challenges,
118 protein target for the Medicines of Malaria Venture validated collection of parasite proliferation i
119 and 27% of the overall treatment effect for venture valuation and exit probability, respectively.
121 who might therefore be useful in cooperative ventures)-was reflected in an increased negativity of N1
126 s stem from an IUPAC-IUBMB-IUPAB inter-union venture with the direct involvement of ICSU and CODATA.
127 s being driven by MMV (Medicines for Malaria Venture), with a number of projects recently reaching th